Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
JCO Precision Oncology|February 8, 2023
Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine CarcinomaStian Knappskog, Tobias Grob, Andreas Venizelos, et al.
ACS Chemical Biology|March 9, 2022
Identification, Characterization, and Synthesis of Natural Parasitic Cysteine Protease Inhibitors: Pentacitidins Are More Potent Falcitidin AnaloguesStephan Brinkmann, Sandra Semmler, Christian Kersten, et al.
British Journal of Cancer|April 25, 2024
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trialAnne Hansen Ree, Jūratė Šaltytė Benth, Hanne M Hamre, et al.
Journal of Medicinal Chemistry|July 18, 2022
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer TreatmentMarvin Schwickert, Tim R Fischer, Robert A Zimmermann, et al.
British Journal of Cancer|June 22, 2024
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasmsHege Elvebakken, Andreas Venizelos, Aurel Perren, et al.
Journal of Medicinal Chemistry|November 27, 2019
Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 ProteasesBenedikt Millies, Franziska von Hammerstein, Andrea Gellert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancerBjørn Naume, Marit Synnestvedt, Ragnhild Sørum Falk, et al.
Endocrine-Related Cancer|October 14, 2021
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasmsAndreas Venizelos, Hege Elvebakken, Aurel Perren, et al.
Endocrine-Related Cancer|July 6, 2023
Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasmsAndreas Venizelos, Halfdan Sorbye, Hege Elvebakken, et al.
Oncoimmunology|July 2, 2024
Complete response of metastatic microsatellite-stable <i>BRAF</i> V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockadeAnne Hansen Ree, Eirik Høye, Ying Esbensen, et al.
Pageof 10